Genesis Molecular AI collaboration expansion

Incyte's quarterly report for the period ended 30 June 2026 says that in May 2026 the company entered a license, research and collaboration agreement with Genesis Molecular AI covering the building and deployment of artificial intelligence to accelerate discovery of novel molecules. Under the agreement, Incyte will identify targets and Genesis will use the Genesis Exploration of Molecular Space artificial intelligence platform to identify molecular structures for each target. The filing says Incyte paid Genesis $120.0 million, made up of an $80.0 million upfront payment and a $40.0 million equity investment.